PFL Heavyweight Gokhan Saricam Suspended for 1 Year After Failed Drug Test
Gokhan Saricam Accepts Sanction for Violation of PFL Anti-Doping Policy https://t.co/U5STdxlebp
— USADA (@usantidoping) July 11, 2024
The 2024 Professional Fighters League campaign for Gokhan Saricam was over before it could begin.
The U.S. Anti-Doping Agency announced on Thursday that Saricam had failed a pair of out-of-competition tests in April and May. The heavyweight from Turkey tested positive for clomiphene and its related metabolites, which are banned both in and out of competition under USADA and PFL policies. As a result, Saricam has been issued a one-year suspension effective the date of the first failed test, April 29.
Advertisement
The full statement from USADA reads as follows:
”USADA announced today that Gokhan Saricam, of Belgium, has accepted a one-year sanction for a violation of the Professional Fighters League (PFL) Anti-Doping Policy.
“Saricam, 33, tested positive for clomiphene and its metabolites as the result of samples collected out-of-competition on April 29, 2024 and May 12, 2024. Because Saricam was not yet notified of the positive tests after both samples were collected, they were treated as a single violation. Clomiphene is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the PFL Anti-Doping Policy and PFL Prohibited List.
Saricam’s one-year period of ineligibility began on April 29, 2024, the date his first positive sample was collected.”
« Previous Pictures: 2024 PFL MENA 2 Regular Season
Next Lightweight, Welterweight Semifinals Crystallize at PFL MENA 2 »
More